An Integrated Experimental-Computational Platform for Evaluating Blood-Brain Barrier Permeability of Novel Kynurenic Acid Derivatives.
An integrated platform linking molecular structure, physicochemical properties, and BBB permeability to support the rational evaluation and prioritisation of compounds within the investigated KYNA derivative series is established.